Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2014 Jul;78(1):170-83.
doi: 10.1111/bcp.12314.

Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults

Katja M Hakkarainen  1 , Hanna Gyllensten, Anna K Jönsson, Karolina Andersson Sundell, Max Petzold, Staffan Hägg
Affiliations

Prevalence, nature and potential preventability of adverse drug events - a population-based medical record study of 4970 adults

Katja M Hakkarainen et al. Br J Clin Pharmacol. 2014 Jul.

Abstract

Aims: To estimate the 3 month prevalence of adverse drug events (ADEs), categories of ADEs and preventable ADEs, and the preventability of ADEs among adults in Sweden. Further, to identify drug classes and organ systems associated with ADEs and estimate their seriousness.

Methods: A random sample of 5025 adults in a Swedish county council in 2008 was drawn from the Total Population Register. All their medical records in 29 inpatient care departments in three hospitals, 110 specialized outpatient clinics and 51 primary care units were reviewed retrospectively in a stepwise manner, and complemented with register data on dispensed drugs. ADEs, including adverse drug reactions (ADRs), sub-therapeutic effects of drug therapy (STEs), drug dependence and abuse, drug intoxications from overdose, and morbidities due to drug-related untreated indication, were detected during a 3 month study period, and assessed for preventability.

Results: Among 4970 included individuals, the prevalence of ADEs was 12.0% (95% confidence interval (CI) 11.1, 12.9%), and preventable ADEs 5.6% (95% CI 5.0, 6.2%). ADRs (6.9%; 95% CI 6.2, 7.6%) and STEs (6.4%; 95% CI 5.8, 7.1%) were more prevalent than the other ADEs. Of the ADEs, 38.8% (95% CI 35.8-41.9%) was preventable, varying by ADE category and seriousness. ADEs were frequently associated with nervous system and cardiovascular drugs, but the associated drugs and affected organs varied by ADE category.

Conclusions: The considerable burden of ADEs and preventable ADEs from commonly used drugs across care settings warrants large-scale efforts to redesign safer, higher quality healthcare systems. The heterogeneous nature of the ADE categories should be considered in research and clinical practice for preventing, detecting and mitigating ADEs.

Keywords: adverse drug event; medical records; medication error; pharmacoepidemiology; prevalence.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Study flow diagram. ADE, adverse drug event. Data sources were linked using the unique personal identity number
See this image and copyright information in PMC

References

    1. Department of Health. Safety First: A Report for Patients, Clinicians and Healthcare Managers. London: Department of Health; 2006.
    1. World Health Organization. WHO Patient Safety Research – Better Knowledge for Safer Care. Geneva: World Health Organization; 2009.
    1. European Medicines Agency. Medication-Errors Workshop Report. London: European Medicines Agency; 2013.
    1. Ministry of Health and Social Affairs. National Medication Strategy. Stockholm: Ministry of Health and Social Affairs; 2011. [in Swedish]
    1. Bates DW, Cullen DJ, Laird N, Petersen LA, Small SD, Servi D, Laffel G, Sweitzer BJ, Shea BF, Hallisey R. Incidence of adverse drug events and potential adverse drug events: implications for prevention. ADE Prevention Study Group. JAMA. 1995;274:29–34. - PubMed

Publication types